(Guangzhou, January 8, 2026) — Cell Valley Group announced today that its wholly-owned subsidiary, Guangzhou Cell Valley Biopharmaceutical Co., Ltd. (hereinafter referred to as "Guangzhou Cell Valley"), has been officially registered with the Guangzhou Municipal Administration for Market Regulation. With a registered capital of RMB 10 million and located in Tianhe District, Guangzhou, the company will serve as a key strategic R&D and production base for Cell Valley Group in Guangzhou and surrounding regions.

The establishment of Guangzhou Cell Valley marks a pivotal step in the Cell Valley Group's national market expansion. As a key strategic unit of the Cell Valley Group in the fields of health and cell-based medicine, Guangzhou Cell Valley will focus on the market promotion of cell therapy products, biopharmaceutical technical services, expansion of industrial partnerships, and regional clinical application promotion. Leveraging the Group's technological expertise and industrial resource advantages in cell therapy, stem cell technology, and immune cell products, the company will further strengthen its scientific and technological service capabilities and enhance the construction of a regional medical innovation ecosystem.

Professor Shi Yuanyuan, Chairman of Cell Valley Group, stated: "The registration of Guangzhou Cell Valley marks a significant milestone in the implementation of the Group's regional strategy. As one of the core hub cities for China's biopharmaceutical industry, Guangzhou boasts comprehensive R&D resources, robust industrial support, and a favorable policy environment. Leveraging the rapid development opportunities within the Greater Bay Area's biopharmaceutical sector, Guangzhou Cell Valley will be dedicated to advancing the industrialization of cell technologies, contributing to the enhancement of regional medical service standards and the innovation ecosystem of the industry."

Dr. Xiang Hua, Executive Director and Legal Representative of Guangzhou Cell Valley, stated: "Guangzhou Cell Valley will systematically deploy its strategies around the localized promotion of cell therapy products, clinical translation collaborations, and regional industrial incubation. We will strengthen in-depth cooperation with universities, research institutions, and medical units to serve clinical research and the translational application of new biomedical technologies, driving the landing and application of more high-quality innovative achievements within the Guangzhou region."

About Cell Valley Group

Cell Valley Group is a comprehensive enterprise group focused on cell technology and biopharmaceutical innovation. Its business covers the R&D of cell therapy products, industrialization services, and the promotion and market expansion of biotechnology solutions. Committed to advancing the transformation of cutting-edge cell medicine achievements through technological innovation and industrial synergy, the Group provides solid scientific and technological support for enhancing public health. The group has established wholly-owned subsidiaries in major cities including Beijing, Shenzhen, Wuhan, Hong Kong, Zhongshan, and Guangzhou.